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Background. A-type lamins, predominantly lamins A and C, are nuclear intermediate filaments believed to act as scaffolds for
assembly of transcription factors. Lamin A/C is necessary for the retinoblastoma protein (pRB) stabilization through unknown
mechanism(s). Two oncoproteins, gankyrin and MDM2, are known to promote pRB degradation in other contexts.
Consequently, we tested the hypothesis that gankyrin and/or MDM2 are required for enhanced pRB degradation in Lmna
2/2
fibroblasts. Principal Findings. To determine if gankyrin promotes pRB destabilization in the absence of lamin A/C, we first
analyzed its protein levels in Lmna
2/2 fibroblasts. Both gankyrin mRNA levels and protein levels are increased in these cells,
leading us to further investigate its role in pRB degradation. Consistent with prior reports, overexpression of gankyrin in
Lmna
+/+ cells destabilizes pRB. This decrease is functionally significant, since gankyrin overexpressing cells are resistant to
p16
ink4a-mediated cell cycle arrest. These findings suggest that lamin A-mediated degradation of pRB would be gankyrin-
dependent. However, effective RNAi-enforced reduction of gankyrin expression in Lmna
2/2 cells was insufficient to restore
pRB stability. To test the importance of MDM2, we disrupted the MDM2-pRB interaction by transfecting Lmna
2/2 cells with
p14
arf. p14
arf expression was also insufficient to stabilize pRB or confer cell cycle arrest, suggesting that MDM2 also does not
mediate pRB degradation in Lmna
2/2 cells. Conclusions/Significance. Our findings suggest that pRB degradation in Lmna
2/
2 cells occurs by gankyrin and MDM2-independent mechanisms, leading us to propose the existence of a third proteasome-
dependent pathway for pRB degradation. Two findings from this study also increase the likelihood that lamin A/C functions as
a tumor suppressor. First, protein levels of the oncoprotein gankyrin are elevated in Lmna
2/2 fibroblasts. Second, Lmna
2/2
cells are refractory to p14
arf-mediated cell cycle arrest, as was previously shown with p16
ink4a. Potential roles of lamin A/C in
the suppression of tumorigenesis are discussed.
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INTRODUCTION
A-type nuclear lamins are intermediate filament proteins that
contribute to the organization and maintenance of the nuclear
structure [1,2]. The A-type lamins (predominantly Lamins A and
C, two alternatively spliced products of the LMNA gene), along
with B-type lamins comprise a protein meshwork underlying the
inner nuclear membrane known as the nuclear lamina [3]. A-type
lamins also localize to internal regions of the nucleus [4,5].
Biochemical studies have shown that lamin A/C can interact with
different gene regulators including SREBP1 [6], MOK2 [7], and
the retinoblastoma protein, pRB [8,9]. pRB regulates cell cycle
progression by inhibiting the activity of the transcriptional
activator E2F and through establishment of repressive chromatin
structures at genes necessary for S phase entry and progression
[10,11]. When active, hypophosphorylated pRB can arrest cells
during the G1 phase of the cell cycle [12,13]. By regulating
expression and/or activity of pRB, A-type lamins can regulate
both gene expression and cellular proliferation.
Several lines of evidence indicate that A-type lamins and pRB
are physically and functionally linked [14,15]. For instance, during
the G1 phase of the cell cycle hypophosphorylated pRB is
anchored to the nuclear matrix by directly binding to lamin A/C
and a lamin associated protein, LAP2alpha [8,16–19]. In addition,
pRB localizes to internal nuclear foci enriched in lamin A/C [5].
This nuclear tethering is important for pRB function since cells
lacking A-type lamins possess decreased pRB levels and resistance
to p16
ink4a-induced G1 arrest [20–22], a phenotype associated
with cells deficient in pRB [23] . Consistently, reducing expression
of LAP2alpha by siRNAs also reduces pRB levels, further
supporting a ‘‘scaffolding’’ model in which pRB activity depends
on its attachment to lamin A/C or LAP2alpha [24]. In the
absence of lamin A/C, pRB is degraded in a proteasome-
dependent manner suggesting that A-type lamins protect pRB
from degradation. However, the mechanism by which A-type
lamins stabilize pRB is currently unknown [21,22].
Recently an oncoprotein, gankyrin, was shown to interact and
stimulate pRB degradation [25,26]. Gankyrin was identified as the
p28 component of the 26S proteasome [27–29], and as an
overexpressed gene from cDNA libraries from hepatocellular
carcinomas (HCC) [25,30]. Gankyrin was found to alter the
Academic Editor: Dong-Yan Jin, University of Hong Kong, China
Received June 21, 2007; Accepted September 6, 2007; Published September 26,
2007
Copyright:  2007 Nitta et al. This is an open-access article distributed under
the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the
original author and source are credited.
Funding: This research was supported by the National Institutes of Health grant
R01AG024287 to BKK. RTN. was supported by the NIH training grant AG013280.
Competing Interests: The authors have declared that no competing interests
exist.
* To whom correspondence should be addressed. E-mail: bkenn@u.washington.
edu
¤ Current address: Department of Neurosurgery, Cancer Biology Program,
Stanford University Medical Center, Stanford, California, United States of America
PLoS ONE | www.plosone.org 1 September 2007 | Issue 9 | e963phosphorylation status of pRB, leading to increased phosphory-
lation at specific residues [25]. This altered phosphorylation is
reportedly linked to the ability of gankyrin to enter a ternary
complex with cyclin D and CDK4, altering CDK4 specificity for
serine residues on pRB. Gankyrin also competes with p16
ink4a for
CDK4 association [31]. The exact mechanism in which gankyrin
degrades pRB in a proteasome-dependent manner is unknown.
One model posits that gankyrin directly binds to pRB, thereby
targeting pRB to the 26S proteasome [32]. Another model
suggests that gankyrin may facilitate an interaction between pRB
and an E3 ubiquitin ligase, MDM2 [33]. MDM2 is a well-
documented oncogene that targets p53 for degradation [34].
MDM2 also interacts with and stimulates proteasome-dependent
pRB degradation [35–37].
Since gankyrin and MDM2 can target pRB for degradation,
either or both proteins may be required for pRB degradation in
the absence of A-type lamins. For example, lamin A/C may
control gankyrin or MDM2 activity, or lamin A/C may regulate
pRB in a manner that keeps it inaccessible from these proteins. To
examine these possibilities, we have examined gankyrin and
MDM2 function in Lmna
2/2 cells. While gankyrin levels are
elevated in Lmna
2/2 fibroblasts, we were unable to find evidence
supporting a role for gankyrin or MDM2 in pRB degradation in
this context. These findings suggest that in the absence on A-type
lamins, pRB degradation occurs by a third, undefined pathway.
Our findings do, however provide further support to the assertion
that A-type lamins act as tumor suppressors [38,39].
RESULTS
Gankyrin levels are increased in cells lacking A-type
lamins
We previously determined that lamin A/C protects pRB from
proteasome-dependent degradation, however, the exact mecha-
nism is still unknown [38,40]. Two proteins, gankyrin and MDM2,
were reported to target pRB for degradation [25,35–37], leading
us to ascertain whether either of these proteins are required for
pRB degradation in Lmna
2/2 cells. For gankyrin, two possibilities
were considered. First, cells lacking lamin A/C may have elevated
levels or activity of gankyrin, leading to pRB degradation. A
second possibility is that pRB is more accessible to gankyrin,
perhaps as a result of mislocalization [40], in Lmna
2/2 cells.
To test if lamin A/C and gankyrin are functionally linked, we
initially analyzed gankyrin levels in two different cell lines lacking
A-type lamins and their respective controls: (1) immortalized
Lmna
2/2 fibroblasts [40] and (2) NIH3T3 cells with reduced lamin
A/C expression using retrovirally infected siRNAs targeted against
Lmna (siLmna) or enhanced GFP (siEGFP) [38]. Consistent with
our previous findings, total pRB levels are decreased four-fold in
cells lacking lamin A/C (Lmna
2/2 and siLmna cells) compared to
the control cells (Lmna
+/+ and siEGFP cells) [21,22] (Figure 1A).
Interestingly, gankyrin protein levels were increased six-fold in
cells lacking lamin A/C. Previous studies have shown that cells
overexpressing gankyrin have increased pRB phosphorylation at
residue Ser 795, but not residues Ser 807 or Ser 811 [25].
Consistently, we found that cells lacking lamin A/C have
increased phosphorylated pRB levels at Ser 795, but not Ser
807/811, indicative of increased gankyrin activity (Figure 1A).
The increase in Ser 795 phosphorylation is especially notable since
overall pRB levels are significantly reduced in these cells.
Are gankyrin mRNA levels increased in cells lacking lamin
A/C? Quantitative PCR (QPCR) was used to determine whether
increased levels of gankyrin correlated with changes in transcript
levels. When compared to the control cells (Lmna
+/+ and siEGFP
cells), gankyrin transcript levels were increased by four-fold in
Lmna
2/2 cells and increased five-fold in siLmna cells (Figure 1B).
Reintroduction of lamin A restores gankyrin protein
and transcript levels
To attribute increased gankyrin levels specifically to the loss of
lamin A/C, we stably transduced a human lamin A (lamin A-res)
that escapes siRNA detection and is therefore resistant to the
siRNAs expressed in siLmna cells (see Materials and Methods).
Reintroduction of lamin A-res in siLmna cells was sufficient to
increase total pRB levels four-fold (Figure 2A). This finding was
consistent with our previous findings, in which human lamin A
was stably transduced in the Lmna
2/2 cells, resulting in increased
pRB levels [22]. We also determined that gankyrin levels were
decreased six-fold and pRB Ser795 levels were decreased two-fold
indicating that stable lamin A expression was sufficient to restore
normal gankyrin levels and activity in siLmna cells. We attribute
the observation that pRB Ser795 levels were only reduced two-fold
due to the presence of residual gankyrin protein in the lamin A-res
cells. Consistently, QPCR analysis showed that reintroduction of
Figure 1. Gankyrin protein and mRNA levels are increased in cells
lacking A-type lamins.( A) Western analysis comparing relative gankyrin
protein levels in cell lines lacking A-type lamins, Lmna
–/– fibroblasts and
NIH3T3 cells infected with siRNAs targeted to LMNA (siLmna) to the
control cells, Lmna
+/+ fibroblasts or NIH3T3 cells infected with siRNAs
targeted to enhanced GFP (siEGFP). Actin levels indicate equivalent
protein loading here and throughout the manuscript. (B) QPCR analysis
comparing the relative mRNA’s of gankyrin in cells lacking A-type
lamins to the control cells. Data represent averages of triplicate
experiments performed and mRNAs were normalized against Gapdh.
doi:10.1371/journal.pone.0000963.g001
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five-fold compared to the control siLmna cells (Figure 2B).
Overexpression of gankyrin decreases pRB levels
and makes cells p16
ink4a resistant
It has been reported that overexpression of gankyrin leads to pRB
degradation in human osteosarcoma cells [25], a finding we have
replicated (Figure S1). We generated stable cell lines of Lmna
+/+
cells overexpressing gankryin (Lmna
+/+-Gank) or control vector
(Lmna
+/+-Cont) to determine whether overexpression of gankyrin
is also sufficient to destabilize pRB in immortalized mouse
fibroblasts. We found that Lmna
+/+-Gank fibroblasts have six-fold
decreased pRB levels compared to Lmna
+/+-Cont cells (Figure 3A).
This decrease of pRB was similar to that in Lmna
2/2 cells
indicating that overexpression of gankyrin yielded a similar cellular
phenotype as loss of A-type lamins. Consistently, pRB Ser795
levels were increased in the Lmna
+/+-Gank cells and the Lmna
2/2
cells. Also p53 levels were decreased four-fold, consistent with
previous reports showing that overexpression of gankyrin leads to
p53 instability [41]. However, we did not observe a difference in
p53 levels between Lmna
2/2 cells and Lmna
+/+-Cont cells
(Figure 3A). To test if the Lmna
+/+-Gank cells have insufficient
pRB function to maintain proper cell cycle regulation, we
introduced GFP-p16
ink4a and examined the proliferative state of
the cells by scoring BrdU incorporation into DNA over a 6 hr
Figure 2. Reintroduction of human lamin A restores pRB and
gankyrin expression. NIH3T3 siLmna cells were stably transduced with
human lamin A (lamin A-res) that was designed to contain several silent
codon changes at the target site of the siRNA, thereby rendering it
resistant to the siRNA. (A) Western analysis comparing gankyrin and
pRB protein levels in siLmna expressing lamin A-res (siLmna-lamin A
resist) to siLmna infected with the control vector (siLmna-Cont). (B)
QPCR analysis comparing the relative mRNA’s of gankyrin in siLmna-
lamin A resist cells to siLmna-Cont cells. Data represent averages of
triplicate experiments performed and mRNAs were normalized against
Gapdh.
doi:10.1371/journal.pone.0000963.g002
Figure 3. Overexpression of gankyrin reduces pRB levels and makes
Lmna
+/+ cells refractory to p16
ink4a-induced arrest. (A) Western
analysis of Lmna
+/+ infected with a control plasmid, Lmna
+/+-Cont, or
gankyrin, Lmna
+/+-Gank, and uninfected Lmna
2/2 fibroblasts. Rb
2/2
fibroblasts were included as a control for pRB levels. (B) Cells were
transfected with GFP-p16
ink4a or GFP-p21
cip1 and GFP-positive cells
were scored; S-phase cells were identified by BrdU incorporation. The
percentage of cells positive for GFP and BrdU incorporation were
quantified. Results are shown with standard deviations from triplicate
samples; 150 cells were counted per sample. (C) Flow cytometry was
conducted on Lmna
+/+-Cont and Lmna
+/+-Gank cells transfected with
GFP or GFP-p16
ink4a.
doi:10.1371/journal.pone.0000963.g003
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ink4a-induced cell cycle arrest is known to be
dependent on functional pRB [23]. We previously determined that
the Lmna
2/2 cells were refractory to p16
ink4a-mediated cell cycle
arrest as a consequence of reduced pRB levels [22]. As opposed to
Lmna
+/+-Cont cells, which have a 25% reduction of BrdU positive
cells when transfected with GFP-p16
ink4a compared to cells
transfected with GFP, the levels of BrdU are unchanged in
Lmna
+/+-Gank cells, similar to Lmna
2/2 cells [22] (Figure 3B).
These results suggest that gankyrin overexpression causes
a physiologically relevant reduction in pRB levels in immortalized
Lmna
+/+ fibroblasts.
Another CDK inhibitor, p21
cip1, arrests cells in a RB-in-
dependent manner [42]. If Lmna
+/+-Gank cell cycle dysregulation
is attributable to a loss of pRB function, then these cells should still
undergo p21
cip1-mediated cell cycle arrest. Consistently, we found
that Lmna
+/+-Gank cells arrest normally in response to p21
cip1,
illustrating that gankyrin overexpressing cells behave similarly to
Lmna
2/2 cells and are not resistant to all G1 arrest signals
(Figure 3B).
To confirm that gankyrin overexpression impedes cell cycle
progression, we conducted flow cytometric analysis on selected
GFP positive cells from GFP-p16
ink4a-transfected cells. As
expected, p16
ink4a confers a 32% increase in the G1-phase cells
and a 25% reduction in S-phase cells in Lmna
+/+-Cont cells, while
the Lmna
+/+-Gank cells remain unresponsive to p16
ink4a over-
expression (Figure 3C).
Reduced expression of gankyrin in cells lacking A-
type lamins does not restore pRB levels or function
If increased levels of gankyrin in cells lacking lamin A/C are
responsible for pRB instability, then pRB levels and function
should be restored if gankyrin levels are decreased. To test this
theory, we used siRNAs to reduce gankyrin expression in Lmna
2/2
cells (Lmna
2/2-siGank), achieving a ten-fold reduction compared
to siRNAs targeted to a control gene, enhanced GFP (Lmna
2/2-
siEGFP) (Figure 4A). The reduction of gankyrin reduced pRB
phosphorylation at Ser 795 five-fold reduction indicating that
gankyrin function was significantly impaired. Even though
gankyrin expression was reduced and its activity significantly
decreased, the total pRB levels remained unchanged in Lmna
2/2-
siGank cells, similar to Lmna
2/2-siEGFP cells (Figure 4A).
Consistently, by indirect immunofluorescence, the intensity of
pRB nuclear foci was dramatically reduced in Lmna
2/2 siGank
and Lmna
2/2-siEGFP cells compared to Lmna
+/+ cells
(Figure 4B). To confirm that Lmna
2/2-siGank have insufficient
pRB function to mediate cell cycle arrest, GFP-p16
ink4a was
introduced and BrdU incorporation was monitored. Both Lmna
2/
2-siGank and Lmna
2/2-siGFP cells remained refractory to
p16
ink4a-mediated cell cycle arrest (Figure 4C). One possible
explanation for this finding is that the Lmna
2/2 cells used for these
studies have been immortalized and may have mutations and/or
altered expression in other genes that promote pRB destabilization
(e.g. MDM2). To test this possibility we used siRNAs to reduce
gankyrin expression in siLmna cells (siLmna/siGank cells).
Although we were able to reduce both gankyrin and lamin A/C
levels seven and ten-fold, respectively, and pRB phosphorylation
at Ser795 was decreased five-fold, total pRB levels were still five-
fold less than the siEGFP control cells (Figure 4A). We also
verified that siLmna/siGank cells remained resistant to p16
ink4a-
induced arrest, and found no significant change compared to
siLmna cells (Figure 4C). Overall, reduction of gankyrin in two
cell lines lacking A-type lamins did not lead to enhanced pRB
levels or restoration of p16
ink4a sensitivity suggesting that gankyrin
is not solely involved in lamin A/C stability of pRB. We cannot
completely rule out a role for gankyrin in these cells, since residual
levels of the protein may be sufficient to mediate pRB degradation
in siGank cells. A complete knockout of gankyrin would be
necessary to examine this possibility. Another possibility is that loss
of lamin A/C leads to degradation of pRB through multiple
pathways one of which being gankyrin-dependent (see Discussion).
MDM2 levels are increased in immortalized Lmna
2/2
cells, but not siLmna cells
MDM2 was previously shown to stimulate pRB degradation in
a proteasome-dependent manner [36,37]. Increased MDM2 levels
and/or activity in Lmna
2/2 cells may therefore be another avenue
toward proteasome-dependent pRB degradation. To examine this
possibility, we determined MDM2 levels in cells lacking lamin
A/C. Again and surprisingly, immortalized Lmna
2/2 cells had
Figure 4. Reduction of gankyrin in cells lacking lamin A/C does not
restore pRB or p16
ink4a sensitivity. Cells lacking lamin A/C (Lmna
2/2
and NIH3T3 siLmna cells) were infected with siRNAs targeted to
gankyrin (siGank) or siRNAs targeted to a control gene, enhanced GFP
(siEGFP). (A) Western blot analysis comparing cells lacking lamin A/C
and gankyrin (Lmna
2/2-siGank and siLmna/siGank) to cells only lacking
lamin A/C. (B) Indirect immunofluorescence of Lmna
2/2-siGank, Lmna
2/
2-siEGFP cells, and litter-mate control Lmna
+/+ cells. Images comparing
the cells were collected using equal exposure times and image
processing. (C) Cells were transfected with GFP-p16
ink4a or GFP-
p21
cip1 and the S-phase cells were identified by BrdU incorporation.
The percentage of cells positive for GFP and BrdU incorporation were
quantified.
doi:10.1371/journal.pone.0000963.g004
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gankyrin, MDM2 levels were not elevated in siLmna cells. One
explanation for these disparate findings is that elevated MDM2
levels in Lmna
2/2 immortalized fibroblasts is an indirect
consequence of the immortalization process and not related to
loss of lamin A/C. It is possible that MDM2 may be required for
pRB degradation even though its levels were not increased.
Consequently, we used siLmna cells to test the importance of
MDM2 for pRB destabilization in cells lacking lamin A/C.
Disruption of the MDM2-pRB interaction does not
restore pRB levels and function in siLmna cells
To determine if MDM2 is involved in pRB stability in siLmna
cells, we prevented pRB from interacting with MDM2 in siLmna
cells. Previous studies have shown that disrupting the interaction
between MDM2 and pRB results in loss of pRB ubiquitination
and degradation, and subsequently increases pRB levels [43]. If
MDM2 is responsible for pRB degradation in cells lacking lamin
A/C, blocking the interaction between pRB and MDM2 should
restore pRB function and levels. To test this theory we generated
a siLmna cell line that stably expressed a V5 tagged p14
arf
(siLmna-p14). p14
arf is a well characterized CDK inhibitor that
inhibits MDM2 function and can prevent the interaction between
MDM2 and pRB, thus causing accumulation of pRB [43].
Western analysis showed that pRB levels in siLmna- p14 cells were
similar to the control infected cells (siLmna-Cont) and seven-fold
reduced compared to the control siEGFP cells (Figure 5A).
Consistently, siLmna-p14
arf cells remained refractory to p16
ink4a
suggesting that the cells had insufficient pRB function to regulate
the cell cycle (Figure 5B).
To verify that ectopic expression of p14
arf was functionally
active, we analyzed p53 levels in the siLmna-p14 cells. According
to previous reports, overexpression of p14
arf stabilizes p53 by
preventing MDM2 from interacting with p53 [44]. Consistently,
overexpression of p14
arf increased p53 levels four-fold in siLmna-
p14 cells compared to siLmna-Cont cells indicating that p14
arf
inhibited MDM2 activity (Figure 5A). In addition, we introduced
GFP-p14
arf by transient transfection into siEGFP and siLmna cells
and examined the proliferative state of the cells by scoring BrdU
incorporation in GFP positive cells. Previous reports indicated that
overexpression of p14
arf increased pRB levels and induced G1
arrest in a pRB dependent manner [43]. Consistently, GFP-p14
arf
reduced the percentage of S-phase cells by 25% compared to the
Figure 5. Expression of p14
arf in siLmna cells does not restore pRB levels or p16
ink4a sensitivity. NIH3T3 siLmna cells were stably transduced with
a V5 tagged p14arf (siLmna-p14) or an empty vector (siLmna-Cont). (A) Western blot analysis comparing pRB levels in siEGFP cells, siLmna-Cont, and
siLmna-p14. (B) Cells were transfected with GFP-p16ink4a or GFP-p21cip1 and the S-phase cells were identified by BrdU incorporation. The
percentage of cells positive for GFP and BrdU incorporation were quantified. (C) siEGFP and siLmna cells were transfected with GFP-p14arf and the
S-phase cells were identified by BrdU incorporation. (D) siEGFP and siLmna cells were transfected with GFP-p14arf and the GFP positive cells were
sorted using FACS analysis.
doi:10.1371/journal.pone.0000963.g005
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siLmna cells was unaffected (Figure 5C). Extracts of flow-sorted
GFP positive cells were prepared and analyzed for pRB levels.
Western analysis showed that GFP-p14
arf overexpression in-
creased pRB levels two-fold in siEGFP cells, while siLmna cells
were resistant to increased pRB levels by GFP-p14
arf over-
expression (Figure 5D).
Overexpression of p14
arf in NIH3T3 cells with
reduced lamin A/C and gankyrin does not restore
pRB levels or p16
ink4a sensitivity
Individually, we found no evidence indicating that gankyrin and
MDM2 are responsible for pRB degradation in cells lacking lamin
A/C. One possible explanation for these findings is that there is
some functional redundancy between gankyrin- and MDM2-
dependent pathways. Therefore, inhibiting the function of one
protein might be insufficient to restore pRB levels and function.
To determine if pRB levels could be restored when both gankyrin
and MDM2 functions were deregulated, we stably transduced V5
tagged p14
arf in NIH3T3 cells with reduced lamin A/C and
gankyrin expression (siLmna/siGank-p14). Western analysis
demonstrated that interference of both MDM2 and gankyrin
was insufficient to stabilize pRB (Figure 6A). Consistently,
siLmna/siGank-p14 cells remained resistant to p16
ink4a-induced
arrest, indicating that reducing gankyrin levels and preventing the
MDM2 and pRB association together were not sufficient to restore
pRB levels in cells lacking lamin A/C (Figure 6B).
DISCUSSION
Gankyrin and MDM2 can both mediate degradation of the
retinoblastoma protein [25,35237]. Given that we have shown
that pRB undergoes enhanced proteasome-dependent degradation
in Lmna
2/2 cells, we determined whether gankyrin and MDM2
have any involvement in this process. We discovered that gankyrin
levels are significantly elevated in Lmna
2/2 fibroblasts; however,
RNAi-mediated reduction in gankyrin levels is insufficient to
restore normal pRB stability to Lmna
2/2 cells, leading us to
consider other pathways regulating pRB stability. Inhibition of
MDM2 activity by overexpression of p14
arf also fails to restore
pRB stability to Lmna
2/2 cells, and fails to confer cell cycle arrest.
Finally, to test the hypothesis that MDM2 and gankyrin degrade
pRB through redundant pathways in the absence of lamin A/C,
p14
arf was expressed in
-cells with reduced gankyrin and lamin A/
C levels, and pRB levels were determined. We found that, again,
pRB levels were not increased. While we cannot completely
exclude a model whereby gankyrin and MDM2 have some
involvement in pRB degradation in the absence of lamin A/C,
these experiments lead us to the hypothesis that a third gankyrin-
independent, MDM2-independent pathway to pRB degradation is
invoked when A-type lamin function is ablated.
The mechanism(s) in which pRB becomes targeted for
proteasome-dependent degradation remains to be well defined.
However, a few other proteins, in addition to gankyrin and
MDM2, have been linked to the pRB degradation [33]. For
instance, viral oncoproteins such as human papillomavirus (HPV)
E7, human cytomegalovirus (CMV) pp71, and Epstein-Barr virus
nuclear antigen 3C (EBNA3C) all lead to pRB destabilization
when expressed in mammalian cells [45–50]. The pathway(s) by
which pRB becomes degraded in the presence of viral proteins
remains to be fully elaborated. For instance, viral proteins have
been reported to target pRB for degradation through both
proteasome-dependent and independent mechanisms [46,47,51].
In addition to pRB, Knight et al. EBNA3C interacts with the SCF
ubiquitin ligase, suggesting a role for this complex in pRB
degradation [49]. Consistently, the expression of a dominant
negative Skp2 restored pRB stability in EBNA3C-expressing cells.
These findings raise the possibility that pRB undergoes increased
exposure to SCF in the absence of lamin A/C leading to its
degradation through this ligase system.
Overexpression of the acetyltransferase Tip60 increases pRB
acetylation and targets the tumor suppressor for proteasome-
dependent degradation [52]. Tip60 is a component of the NuA4
complex that participates in transcriptional activation and the
DNA damage response [53]. We considered the possibility that
increased Tip60-dependent acetylation of pRB might be a con-
tributing factor toward pRB degradation in Lmna
2/2 cells, but
believe this unlikely since increased p14
arf expression is known to
counteract this effect [52], and yet p14
arf was unable to restore
pRB levels in cells lacking lamin A/C. Nevertheless, potential
changes in pRB acetylation associated with loss of A-type lamins
should be determined.
Figure 6. Expression of p14
arf in siLmna/siGank cells does not restore
pRB levels or p16
ink4a sensitivity. NIH3T3 cells were infected with
siRNAs targeted to Lmna and Gankyrin and then stably transduced with
a V5 tagged p14
arf (siLmna/siGank-p14). (A) Western blot analysis
comparing pRB levels in siEGFP cells, siLmna, siLmna/siGank, and
siLmna/siGank-p14. (B) Cells were transfected with GFP-p16
ink4a or
GFP-p21
cip1 and the S-phase cells were identified by BrdU incorpora-
tion. The percentage of cells positive for GFP and BrdU incorporation
were quantified.
doi:10.1371/journal.pone.0000963.g006
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transcription
Gankyrin is a relatively unknown protein that was discovered
within the last ten years. The majority of the gankyrin research has
involved its ability to stimulate proteasome-dependent degradation
of pRB and p53, and its role in pRB phosphorylation [27,32].
Very little information is known about the mechanism of gankyrin
regulation. Gankyrin was identified by increased transcript levels
in hepatocellular carcinomas (HCCs) indicating that gankyrin might
be regulated at the transcriptional level [25]. However, no specific
studies have analyzed gankyrin expression. By analyzing cell lines
that are deficient in lamin A/C, we discovered that in fibroblasts
gankyrin transcript levels are increased four to five-fold and gankyrin
protein levels are increased seven-fold in the absence of A-type
lamins (Figure 1B). While we cannot rule out a model whereby
Lmna
2/2 cells have increased gankyrin mRNA stability and not
transcription, our findings add to the growing evidence that lamin
A/C, either directly or indirectly, is important for regulating a subset
of genes at the transcriptional level [14,20,54–56].
Interestingly, altered transcription of gankyrin in the absence of
lamin A/C, appears to be tissue-specific. QPCR analysis of
myoblasts lacking lamin A/C indicated that, unlike fibroblasts
gankyrin transcript levels are not increased (Figure S2). The
reasons for this tissue-specificity are not known and it would be
interesting to examine the expression of gankyrin in a variety of
tissues from Lmna
2/2 mice, particularly since increased gankyrin
expression is associated with hepatocarcinogenesis [25,26].
Lamin A/C and tumorigenesis
Reduced lamin A/C expression is a common feature of a variety
of different cancers [39], however there is little direct evidence
connecting tumorigenesis to A-type lamins. Through our previous
work we showed that decreased expression of lamin A/C results in
reduced activity of a known tumor suppressor, pRB [21,22]. This
reduction was functionally significant since Lmna
2/2 cells, like
Rb
2/2 cells [23], are refractory to p16
ink4a-mediated cell cycle
arrest [38]
Findings in this report further support a role for A-type lamins
as potential tumor suppressors. In addition to having increased
gankyrin protein levels, we find that Lmna
2/2 cells are refractory
to p14
arf-mediated cell cycle arrest. In addition to RB, p16
ink4a and
p14
arf are linked to cellular senescence and are common targets for
inactivation mutation during carcinogenesis [26]. Since neither of
these key tumor suppressors impede cell cycle progression in
Lmna
2/2 cells, it is more likely that mutations inactivating A-type
lamin function also contribute to tumorigenesis.
MATERIALS AND METHODS
Cell Culture and Plasmid transfection
Immortalized knockout fibroblast cell lines, as well as litter-
matched controls, have been described [5]. All cell lines were
cultured in Dulbecco’s Modified Eagle Media (DMEM) supple-
mented with 10% fetal bovine serum (FBS), 2mM L-glutamine,
10 U/mL penicillin, 10 mg/ml streptomycin. Cells grown to 30%
confluency were transfected using Lipofectamine PLUS (Invitro-
gen). The following constructs were used: pcDNA3.1 GFP,
pcDNA3.1-GFP- p16
ink4a, and pcDNA3.1-GFP-p21
cip1. To de-
termine the percentage of S-phase cells, cells were grown on
coverslips for 36 hours, pulsed with BrdU for 6 hours, then fixed
with 4% paraformaldehyde and detected by immunofluorescence
as previously described [23]. Results were recorded from triplicate
samples, and 150 cells were scored per sample. Each experiment
was repeated three times and the data presented is a representative
sample.
Retroviral infections
The retroviruses pMXIH-V5, pMXIH-gankyrin-V5, pMXIH-
p14
arf-V5, and pMXIH-human lamin A-res were used for
infections [57]. The human lamin A-res plasmid was generated
as described in Frock et al. 2006 [20]. 36 hours after infection,
infected cells were selected by culturing in selective media
containing 500 mg/mL of hygromycin-B for 2 days. The retro-
viruses pLXSN and pLXSN- p14
arf (kind gifts from Marie Classon
Cancer Center, Massachusetts General Hospital) were infected
into cells and were selected for ten days using 600 mg/ml G418.
24 hours before additional transfection, the selective media was
removed from the infected cells and supplemented DMEM
(described above) was added. Infection of retroviral small inhibitory
RNA (siRNA) constructs to mouse gankyrin was conducted as
previously described [57]. The siRNA sequence for mouse
gankyrin is 59-GCCTGGGTTTAATACTCAA -39. Ecotropic
retroviruses of pSuper.retro-Puro (Oligoengine) and pSuper.retro-
Puro siLamin A plasmids was generated as described above. As
a control siRNAs targeted to enhanced GFP were used [57].
24 hours after NIH3T3cells were infected, cells were selected using
5 mg/mL of puromyocin for 3 days. These cells were not used for
experiments more than 6 passages after selection.
Indirect Immunofluorescence
Immunofluorescence was performed on formaldehyde-fixed cells
except for those stained for lamin A/C (SC-20681), which were
methanol-fixed as previously described [5]. The following
antibodies were used: mouse anti-pRB (Pharmingen, G3-245)
and mouse anti-BrdU (Becton Dickinson, 347580). Images were
taken using Zeiss Axiovert 200 (Obserkochen, Germany). Images
that compared protein levels were collected using equal exposure
times and processed similarly.
Protein Analysis
Protein extracts from total cells were harvested in RIPA buffer
(0.15 M NaCl/0.05mM Tris-HCl, pH 7.2/1% NP-40/1%
sodium deoxycholate/0.1% SDS). A total of 40 to 50 mg of total
protein was separated by denaturing electrophoresis. The
following antibodies were used for immunoblotting: mouse anti-
pRB (Pharmingen, G3-245), rabbit anti-pRB Ser795 (Cell
Signaling, 9301), rabbit anti-pRB Ser807/811 (Cell Signaling,
9308), mouse anti-actin (Chemicon, MAB1501R), rabbit anti-
MDM2 (Santa Cruz, H221), anti-mouse V5 (Invitrogen, R960-
25), mouse anti-p53 (Cell Signaling, 1C12), rabbit anti-gankyrin
(Santa Cruz, H-231), rabbit anti-pan lamin A/C (Cell Signaling,
2032), and mouse anti-GFP (Roche, 11814460001). Protein levels
were determined by counting pixels using NIH Image (National
Institute of Health, USA).
Fluorescent Activated Cells Sorting (FACS) analysis
36 hours after transfection, flow cytometry analysis was conducted
on the GFP transfected cells in the Rabinovitch Laboratory (Dept
Pathology, University of Washington). Cells were washed in
a solution of 10 mg/ml 4,6-diamidino-2-phenylindole (DAPI) and
0.1% nonidet P-40 detergent in a Tris buffered saline and then
triturated with a 26 gauge needle and analyzed using a Coulter
ELITE cytometer (Coulter Corp., Miami FL), with ultraviolet
excitation and DAPI emission collected at .450nm [58]. DNA
content and cell cycle were analyzed using the software program
WinCycle software (Phoenix Flow Systems, San Diego, CA) as
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experiment. The data are presented as histograms in which cell
number is plotted against DNA content. Cells were sorted by GFP
expression using a similar manner. Approximately 20,000 cells
were collected per sample and analyzed using western analysis.
Quantitative PCR (QPCR) analysis
mRNA’s were purified using the RNeasy kit (Qiagen). For QPCR,
TaqMan One-Step RT-PCR was mixed with 50 ng of RNA and
to generate cDNA (Applied Biosystems) and 300 mM forward and
reverse primers. Triplicates of the cDNA’s were amplified on the
Opticon I real-time thermal cycler (MJ Research). The experi-
ments were performed three times. PCR products were normal-
ized against the housekeeping gene Gapdh, and measurements
between samples were compared by cycle threshold (Ct). Primer
sequences used for QPCR for the mouse gankyrin
(Mm00450376_m1)) and mouse Gapdh (FAM-MGB) were ob-
tained from Applied Biosystems.
SUPPORTING INFORMATION
Figure S1 Overexpression of gankyrin leads to pRB degradation
by the proteasome in U2OS cells. U2OS cells were stably
transduced with gankyrin-V5 or a vector control and were treated
with a proteasome inhibitor (MG132) and/or cycloheximide
(CHX) for the specified times. Protein samples were separated by
a 8% SDS PAGE and detected by immunoblot with mouse anti-
pRB. The percent of pRB was determined by counting pixel levels
using NIH Image and each time point was normalized to time
0 hr. Actin was used as a loading control.
Found at: doi:10.1371/journal.pone.0000963.s001 (6.38 MB TIF)
Figure S2 QPCR analysis comparing the mRNA’s of gankyrin
in Lmna-/- myoblasts. -/- cells are derived from the Lmna-/-
mouse. +/+ cells are the litter-mate control cells, which possess
endogenous lamin A/C. siLmna cells are NIH3T3 cells with
siRNAs targeted to Lmna. siGFP cells are NIH3T3 cells with
siRNAs targeted to a control gene, enhanced GFP. Gankyrin
mRNA’s are increased four-fold in Lmna-/- fibroblastss and
siLmna cells, compared to the control cells. Lmna-/- myoblasts
possess similar gankyrin mRNA levels as Lmna+/+ myoblasts.
Data represent averages of triplicate experiments performed and
mRNAs were normalized against Gapdh.
Found at: doi:10.1371/journal.pone.0000963.s002 (6.38 MB TIF)
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